Cell line name | HT29-16E |
---|---|
Synonyms | HT29 16E; HT-29 16E; HT29-Cl.16E; HT29 clone 16E; Cl.16E |
Accession | CVCL_C763 |
Resource Identification Initiative | To cite this cell line use: HT29-16E (RRID:CVCL_C763) |
Comments | Misspelling: C1.16E; Occasionally. |
Sequence variations | Heterozygous for APC p.Glu853Ter (c.2557G>T) (from parent cell line).Heterozygous for APC p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA) (ClinVar=VCV000428112) (from parent cell line).Heterozygous for BRAF p.Val600Glu (c.1799T>A) (ClinVar=VCV000013961) (from parent cell line).Heterozygous for PIK3CA p.Pro449Thr (c.1345C>A) (from parent cell line).Homozygous for SMAD4 p.Gln311Ter (c.931C>T) (ClinVar=VCV000230663) (from parent cell line).Homozygous for TP53 p.Arg273His (c.818G>A) (ClinVar=VCV000012366) (from parent cell line). |
Disease | Colon adenocarcinoma (NCIt: C4349) |
Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
Hierarchy | Parent: CVCL_0320 (HT-29) |
Sex of cell | Female |
Age at sampling | 44Y |
Category | Cancer cell line |
Publications | PubMed=6744312 PubMed=8801204; DOI=10.1136/gut.38.2.240 |
Cross-references | |
Other | Wikidata; Q54896586 |
Entry history | |
Entry creation | 22-Oct-2012 |
Last entry update | 12-Jan-2021 |
Version number | 16 |